US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTMX

<< Anterior 1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
08/08/2023	15:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTMX	CytomX Therapeutics Inc
08/08/2023	15:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTMX	CytomX Therapeutics Inc
01/08/2023	07:00	GlobeNewswire Inc.	CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023	NASDAQ:CTMX	CytomX Therapeutics Inc
20/07/2023	16:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTMX	CytomX Therapeutics Inc
20/07/2023	16:17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CTMX	CytomX Therapeutics Inc
20/07/2023	08:00	GlobeNewswire Inc.	CytomX Therapeutics Announces New Employment Inducement Grants	NASDAQ:CTMX	CytomX Therapeutics Inc
17/07/2023	07:00	GlobeNewswire Inc.	CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer	NASDAQ:CTMX	CytomX Therapeutics Inc
30/06/2023	07:00	GlobeNewswire Inc.	CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.	NASDAQ:CTMX	CytomX Therapeutics Inc
20/06/2023	15:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
16/06/2023	16:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
01/06/2023	15:05	GlobeNewswire Inc.	CytomX Therapeutics to Present at the Jefferies Healthcare Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
09/05/2023	15:15	GlobeNewswire Inc.	CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update	NASDAQ:CTMX	CytomX Therapeutics Inc
09/05/2023	15:11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTMX	CytomX Therapeutics Inc
01/05/2023	15:01	GlobeNewswire Inc.	CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023	NASDAQ:CTMX	CytomX Therapeutics Inc
27/04/2023	15:22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CTMX	CytomX Therapeutics Inc
27/04/2023	15:21	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CTMX	CytomX Therapeutics Inc
25/04/2023	15:05	GlobeNewswire Inc.	CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ	NASDAQ:CTMX	CytomX Therapeutics Inc
29/03/2023	18:51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CTMX	CytomX Therapeutics Inc
27/03/2023	15:15	GlobeNewswire Inc.	CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update	NASDAQ:CTMX	CytomX Therapeutics Inc
27/03/2023	15:13	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
27/03/2023	15:09	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:CTMX	CytomX Therapeutics Inc
22/03/2023	18:23	GlobeNewswire Inc.	CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023	NASDAQ:CTMX	CytomX Therapeutics Inc
28/02/2023	15:05	GlobeNewswire Inc.	CytomX Therapeutics to Present at Upcoming March Investor Conferences	NASDAQ:CTMX	CytomX Therapeutics Inc
14/02/2023	15:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CTMX	CytomX Therapeutics Inc
26/01/2023	06:00	GlobeNewswire Inc.	CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas	NASDAQ:CTMX	CytomX Therapeutics Inc
17/01/2023	15:05	GlobeNewswire Inc.	CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
05/01/2023	16:16	Dow Jones News	CytomX Shares Climb 58% on Research Collaboration With Moderna	NASDAQ:CTMX	CytomX Therapeutics Inc
05/01/2023	15:05	GlobeNewswire Inc.	CytomX Therapeutics Provides Business Update and Outlines 2023 Company Priorities	NASDAQ:CTMX	CytomX Therapeutics Inc
05/01/2023	15:05	GlobeNewswire Inc.	CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics	NASDAQ:CTMX	CytomX Therapeutics Inc
22/12/2022	16:00	GlobeNewswire Inc.	CytomX Therapeutics to Outline 2023 Company Priorities and Provide Pipeline Update on January 5, 2023	NASDAQ:CTMX	CytomX Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:CTMX

<< Anterior 1 2 3 4 5 6 7 8 9 Próxima >

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

BNP Paribas (QX)

JP Morgan Chase

American Express

US Dollar vs MXN

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones